Pricing Log in Create free account

Embecta Corp. (EMBC) vs Anbio Biotechnology (NNNN)

Embecta Corp. and Anbio Biotechnology are both Medical Instruments & Supplies companies. Anbio Biotechnology is the larger, with a market value of $516.6M against $358.7M — 1.4× the size. Across the 9 metrics below, Embecta Corp. leads on 5 and Anbio Biotechnology on 4.

Valuation

Metric EMBC NNNN Medical Instruments & Supplies median
P/E 4.24 — 30.28
P/S 0.36 — 2.49
P/B n/m n/m 2.34
Price to free cash flow 2.12 n/m 23.49
EV/EBITDA 5.68 n/m 14.87
EV/Sales 1.60 n/m 2.75
Earnings yield 23.58% — 0.00%
Free cash flow yield 47.27% 0.00% 0.59%

Profitability

Metric EMBC NNNN Medical Instruments & Supplies median
Gross margin 59.03% — 53.60%
Operating margin 21.94% — 1.97%
Net margin 8.59% — 0.00%
Free cash flow margin 17.15% 0.00% 2.36%
Return on equity (13.65%) 0.00% 0.00%
Return on assets 7.22% 0.00% 0.00%
Return on invested capital 21.44% 0.00% 0.13%

Growth

Metric EMBC NNNN Medical Instruments & Supplies median
Revenue growth (TTM) (7.60%) — 8.97%
EPS growth (last fiscal year) 20.90% 150.00% 6.51%
Revenue growth, 5-year CAGR (1.50%) — 8.85%
Net income growth, 5-year CAGR (25.47%) — 0.00%

Health

Metric EMBC NNNN Medical Instruments & Supplies median
Debt to equity (2.42) 0.00 0.10
Current ratio 1.68 344.45 2.47
Net debt to EBITDA 3.96 (2.06) 0.97

Dividend

Metric EMBC NNNN Medical Instruments & Supplies median
Dividend yield 5.06% — 1.02%
Payout ratio 0.22 — 0.27

Size

Metric EMBC NNNN Medical Instruments & Supplies median
Market cap 358.65m 516.57m 1.71b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack